| The effect of cardiac resynchronization on morbidity and mortality in heart failure JGF Cleland, JC Daubert, E Erdmann, N Freemantle, D Gras, ... New England Journal of Medicine 352 (15), 1539-1549, 2005 | 6952 | 2005 |
| Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a … JA Dormandy, B Charbonnel, DJA Eckland, E Erdmann, ... The Lancet 366 (9493), 1279-1289, 2005 | 5300 | 2005 |
| Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of … L Rydén, E Standl, M Bartnik, G Van den Berghe, J Betteridge, ... European heart journal 28 (1), 88-136, 2007 | 2155 | 2007 |
| Adaptive servo-ventilation for central sleep apnea in systolic heart failure MR Cowie, H Woehrle, K Wegscheider, C Angermann, MP d’Ortho, ... New England Journal of Medicine 373 (12), 1095-1105, 2015 | 1167 | 2015 |
| Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. M Ungerer, M Böhm, JS Elce, E Erdmann, MJ Lohse Circulation 87 (2), 454-463, 1993 | 1124 | 1993 |
| Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. DJ Beuckelmann, M Näbauer, E Erdmann Circulation 85 (3), 1046-1055, 1992 | 1102 | 1992 |
| Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. DJ Beuckelmann, M Näbauer, E Erdmann Circulation research 73 (2), 379-385, 1993 | 945 | 1993 |
| Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] JGF Cleland, JC Daubert, E Erdmann, N Freemantle, D Gras, ... European heart journal 27 (16), 1928-1932, 2006 | 878 | 2006 |
| Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension MC Brandt, F Mahfoud, S Reda, SH Schirmer, E Erdmann, M Böhm, ... Journal of the American College of Cardiology 59 (10), 901-909, 2012 | 755 | 2012 |
| Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long … CP Cannon, SP Curtis, GA FitzGerald, H Krum, A Kaur, JA Bolognese, ... The Lancet 368 (9549), 1771-1781, 2006 | 745 | 2006 |
| Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results … R Willenheimer, DJ van Veldhuisen, B Silke, E Erdmann, F Follath, ... Circulation 112 (16), 2426-2435, 2005 | 667 | 2005 |
| Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey M Komajda, P Lapuerta, N Hermans, JR Gonzalez-Juanatey, ... European heart journal 26 (16), 1653-1659, 2005 | 553 | 2005 |
| The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive … E Erdmann, JA Dormandy, B Charbonnel, M Massi-Benedetti, IK Moules, ... Journal of the American College of Cardiology 49 (17), 1772-1780, 2007 | 523 | 2007 |
| Unchanged Protein Levels of SERCA II and Phospholamban but Reduced Ca2+ Uptake and Ca2+-ATPase Activity of Cardiac Sarcoplasmic Reticulum From … RHG Schwinger, M Böhm, U Schmidt, P Karczewski, U Bavendiek, ... Circulation 92 (11), 3220-3228, 1995 | 507 | 1995 |
| An atypical variant of Fabry's disease with manifestations confined to the myocardium W Scheidt, CM Eng, TF Fitzmaurice, E Erdmann, G Hübner, EGJ Olsen, ... New England Journal of Medicine 324 (6), 395-399, 1991 | 487 | 1991 |
| The CARE‐HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end‐points JGF Cleland, JC Daubert, E Erdmann, N Freemantle, D Gras, ... European journal of heart failure 3 (4), 481-489, 2001 | 403 | 2001 |
| Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. M Böhm, P Gierschik, KH Jakobs, B Pieske, P Schnabel, M Ungerer, ... Circulation 82 (4), 1249-1265, 1990 | 403 | 1990 |
| Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization FM Baer, P Theissen, CA Schneider, E Voth, U Sechtem, H Schicha, ... Journal of the American College of Cardiology 31 (5), 1040-1048, 1998 | 400 | 1998 |
| Reduced Ca2+-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phoshorylation RHG Schwinger, G Münch, B Bölck, P Karczewski, EG Krause, ... Journal of molecular and cellular cardiology 31 (3), 479-491, 1999 | 399 | 1999 |
| Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. M Ungerer, G Parruti, M Böhm, M Puzicha, A DeBlasi, E Erdmann, ... Circulation research 74 (2), 206-213, 1994 | 367 | 1994 |
